The impact of delayed sample handling and type of anticoagulant on the interpretation of dysplastic signs detected by flow cytometry

Bettina Kárai, Zsófia Miltényi, L. Gergely, Marianna Száraz-Széles, J. Kappelmayer, Zsuzsanna Hevessy

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Introduction: A growing body of evidence supports the usefulness of dysplastic signs detected by flow cytometry in the diagnosis of myelodysplastic syndromes (MDS). Our aim was to assess the impact of pre-analytical variables (delayed sample handling, type of anticoagulant, and different clones of antibody) in the interpretation of flow cytometric results. Material and methods: Bone marrow samples were labelled and analysed immediately after aspiration and on two consecutive days. The effect of anticoagulant type was evaluated in 16 bone marrow samples. Thirty-seven different immunophenotypic variables were recorded after eight-co-lour staining. Furthermore, 8 normal peripheral blood samples collected in K3-EDTA and Na-heparin were examined with different clones of CD11b antibodies and four parameters were recorded with both anticoagulants on two consecutive days. Results: Fourteen significant differences were detected in the initial immunophenotype of fresh samples collected in K3-EDTA and Na-heparin. Regardless of the anticoagulant type, eleven parameters remained stable despite delayed sample handling. Due to delayed sample processing, more alterations were detected in the samples collected in K3-EDTA than in the samples collected in Na-heparin. The type of CD11b clone influenced the reduction of fluorescence intensity only in samples collected in K3-EDTA, where the alterations were contrary to the changes observed in Na-heparin. Conclusions: Delayed sample processing causes considerable immunohenotypic alterations, which can lead to false interpretation of the results. If delayed sample evaluation is unavoidable, markers that remain more stable over time should be considered with more weight in the diagnosis of MDS.

Original languageEnglish
Article number020704
JournalBiochemia Medica
Volume28
Issue number2 Special Issue
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Flow cytometry
Edetic Acid
Anticoagulants
Heparin
Flow Cytometry
Clone Cells
Myelodysplastic Syndromes
Bone
Bone Marrow
Antibodies
Processing
Blood
Fluorescence
Staining and Labeling
Weights and Measures

Keywords

  • Flow cytometry
  • Myelodysplastic syndromes
  • Pre-analytical error

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

The impact of delayed sample handling and type of anticoagulant on the interpretation of dysplastic signs detected by flow cytometry. / Kárai, Bettina; Miltényi, Zsófia; Gergely, L.; Száraz-Széles, Marianna; Kappelmayer, J.; Hevessy, Zsuzsanna.

In: Biochemia Medica, Vol. 28, No. 2 Special Issue, 020704, 01.01.2018.

Research output: Contribution to journalArticle

Kárai, Bettina ; Miltényi, Zsófia ; Gergely, L. ; Száraz-Széles, Marianna ; Kappelmayer, J. ; Hevessy, Zsuzsanna. / The impact of delayed sample handling and type of anticoagulant on the interpretation of dysplastic signs detected by flow cytometry. In: Biochemia Medica. 2018 ; Vol. 28, No. 2 Special Issue.
@article{8274c6ae89674c829b887bc4327250ec,
title = "The impact of delayed sample handling and type of anticoagulant on the interpretation of dysplastic signs detected by flow cytometry",
abstract = "Introduction: A growing body of evidence supports the usefulness of dysplastic signs detected by flow cytometry in the diagnosis of myelodysplastic syndromes (MDS). Our aim was to assess the impact of pre-analytical variables (delayed sample handling, type of anticoagulant, and different clones of antibody) in the interpretation of flow cytometric results. Material and methods: Bone marrow samples were labelled and analysed immediately after aspiration and on two consecutive days. The effect of anticoagulant type was evaluated in 16 bone marrow samples. Thirty-seven different immunophenotypic variables were recorded after eight-co-lour staining. Furthermore, 8 normal peripheral blood samples collected in K3-EDTA and Na-heparin were examined with different clones of CD11b antibodies and four parameters were recorded with both anticoagulants on two consecutive days. Results: Fourteen significant differences were detected in the initial immunophenotype of fresh samples collected in K3-EDTA and Na-heparin. Regardless of the anticoagulant type, eleven parameters remained stable despite delayed sample handling. Due to delayed sample processing, more alterations were detected in the samples collected in K3-EDTA than in the samples collected in Na-heparin. The type of CD11b clone influenced the reduction of fluorescence intensity only in samples collected in K3-EDTA, where the alterations were contrary to the changes observed in Na-heparin. Conclusions: Delayed sample processing causes considerable immunohenotypic alterations, which can lead to false interpretation of the results. If delayed sample evaluation is unavoidable, markers that remain more stable over time should be considered with more weight in the diagnosis of MDS.",
keywords = "Flow cytometry, Myelodysplastic syndromes, Pre-analytical error",
author = "Bettina K{\'a}rai and Zs{\'o}fia Milt{\'e}nyi and L. Gergely and Marianna Sz{\'a}raz-Sz{\'e}les and J. Kappelmayer and Zsuzsanna Hevessy",
year = "2018",
month = "1",
day = "1",
doi = "10.11613/BM.2018.020704",
language = "English",
volume = "28",
journal = "Biochemia Medica",
issn = "1330-0962",
publisher = "Biochemia Medica, Editorial Office",
number = "2 Special Issue",

}

TY - JOUR

T1 - The impact of delayed sample handling and type of anticoagulant on the interpretation of dysplastic signs detected by flow cytometry

AU - Kárai, Bettina

AU - Miltényi, Zsófia

AU - Gergely, L.

AU - Száraz-Széles, Marianna

AU - Kappelmayer, J.

AU - Hevessy, Zsuzsanna

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Introduction: A growing body of evidence supports the usefulness of dysplastic signs detected by flow cytometry in the diagnosis of myelodysplastic syndromes (MDS). Our aim was to assess the impact of pre-analytical variables (delayed sample handling, type of anticoagulant, and different clones of antibody) in the interpretation of flow cytometric results. Material and methods: Bone marrow samples were labelled and analysed immediately after aspiration and on two consecutive days. The effect of anticoagulant type was evaluated in 16 bone marrow samples. Thirty-seven different immunophenotypic variables were recorded after eight-co-lour staining. Furthermore, 8 normal peripheral blood samples collected in K3-EDTA and Na-heparin were examined with different clones of CD11b antibodies and four parameters were recorded with both anticoagulants on two consecutive days. Results: Fourteen significant differences were detected in the initial immunophenotype of fresh samples collected in K3-EDTA and Na-heparin. Regardless of the anticoagulant type, eleven parameters remained stable despite delayed sample handling. Due to delayed sample processing, more alterations were detected in the samples collected in K3-EDTA than in the samples collected in Na-heparin. The type of CD11b clone influenced the reduction of fluorescence intensity only in samples collected in K3-EDTA, where the alterations were contrary to the changes observed in Na-heparin. Conclusions: Delayed sample processing causes considerable immunohenotypic alterations, which can lead to false interpretation of the results. If delayed sample evaluation is unavoidable, markers that remain more stable over time should be considered with more weight in the diagnosis of MDS.

AB - Introduction: A growing body of evidence supports the usefulness of dysplastic signs detected by flow cytometry in the diagnosis of myelodysplastic syndromes (MDS). Our aim was to assess the impact of pre-analytical variables (delayed sample handling, type of anticoagulant, and different clones of antibody) in the interpretation of flow cytometric results. Material and methods: Bone marrow samples were labelled and analysed immediately after aspiration and on two consecutive days. The effect of anticoagulant type was evaluated in 16 bone marrow samples. Thirty-seven different immunophenotypic variables were recorded after eight-co-lour staining. Furthermore, 8 normal peripheral blood samples collected in K3-EDTA and Na-heparin were examined with different clones of CD11b antibodies and four parameters were recorded with both anticoagulants on two consecutive days. Results: Fourteen significant differences were detected in the initial immunophenotype of fresh samples collected in K3-EDTA and Na-heparin. Regardless of the anticoagulant type, eleven parameters remained stable despite delayed sample handling. Due to delayed sample processing, more alterations were detected in the samples collected in K3-EDTA than in the samples collected in Na-heparin. The type of CD11b clone influenced the reduction of fluorescence intensity only in samples collected in K3-EDTA, where the alterations were contrary to the changes observed in Na-heparin. Conclusions: Delayed sample processing causes considerable immunohenotypic alterations, which can lead to false interpretation of the results. If delayed sample evaluation is unavoidable, markers that remain more stable over time should be considered with more weight in the diagnosis of MDS.

KW - Flow cytometry

KW - Myelodysplastic syndromes

KW - Pre-analytical error

UR - http://www.scopus.com/inward/record.url?scp=85049651693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049651693&partnerID=8YFLogxK

U2 - 10.11613/BM.2018.020704

DO - 10.11613/BM.2018.020704

M3 - Article

C2 - 29666557

AN - SCOPUS:85049651693

VL - 28

JO - Biochemia Medica

JF - Biochemia Medica

SN - 1330-0962

IS - 2 Special Issue

M1 - 020704

ER -